Showing results (91-100 of 262) with videos related to

Sort By:
Pageof 27
Cancer Research and Treatment|July 27, 2016
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic LeukemiaMathias Lutz, Arik B Schulze, Elisabeth Rebber, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2026
Survival Outcomes After Front-Line Consolidation With High-Dose Melphalan and Autologous Stem Cell Transplantation in Younger and Elderly Multiple Myeloma Patients: A Retrospective Bi-Centric AnalysisArne Strotmann, Theo Leitner, Paolo Mazzeo, et al.
Cancer Medicine|May 21, 2024
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in EuropeEnver Aydilek, Gerald Wulf, Friedrich Schwarz, et al.
Bone Marrow Transplantation|May 3, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patientsPhilipp Berning, Lina Kolloch, Christian Reicherts, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screenLloyd T Lam, R Eric Davis, Vu N Ngo, et al.
Leukemia|March 28, 2024
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trialMichael Oertel, Marita Ziepert, Fabian Frontzek, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and CytopathologyEvgenii Shumilov, Paolo Mazzeo, Martin S Zinkernagel, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2020
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center AnalysisPatrick Stelmach, Klaus Wethmar, Christoph Groth, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2018
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin LymphomasBruce D Cheson, Susan O'Brien, Michael S Ewer, et al.
Pageof 27